AsiaMedic Limited (SGX:505)

AsiaMedic Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.99	4.6	6.64	9.47	7.66
Short-Term Investments	3.49	4.97	1.98	-	0.48
Cash & Short-Term Investments	11.48	9.58	8.62	9.47	8.14
Cash Growth	19.85%	11.06%	-8.98%	16.39%	141.64%
Accounts Receivable	4.08	2.81	3.01	2.1	2.45
Other Receivables	1.09	0.05	0.02	0.02	0.11
Receivables	5.17	2.86	3.03	2.12	2.56
Inventory	0.32	0.36	0.26	0.25	0.27
Prepaid Expenses	0.27	0.33	0.29	0.19	0.17
Restricted Cash	0.48	0.56	0.91	0.82	0.82
Other Current Assets	-	0.47	0.43	0.6	-
Total Current Assets	17.71	14.16	13.54	13.46	11.95
Property, Plant & Equipment	25.96	11.04	8	4.22	2.39
Long-Term Investments	2.2	2.55	2.19	1.99	1.93
Goodwill	-	0.05	-	0.52	0.52
Long-Term Deferred Tax Assets	0.89	0.89	-	-	-
Other Long-Term Assets	-	0.26	-	-	-
Total Assets	46.75	28.95	23.73	20.19	16.8
Accounts Payable	1.64	2	1.48	1.11	1.05
Accrued Expenses	-	1.61	1.38	1.6	1.07
Current Portion of Long-Term Debt	2.35	0.2	-	-	-
Current Portion of Leases	-	1.52	0.94	1.2	1.37
Current Unearned Revenue	0.64	0.86	0.99	1.18	1.36
Other Current Liabilities	4.77	0.62	0.49	0.36	0.64
Total Current Liabilities	9.4	6.81	5.27	5.45	5.49
Long-Term Debt	18.8	0.39	-	-	-
Long-Term Leases	-	7.31	6.38	4.85	2.66
Long-Term Deferred Tax Liabilities	0.02	0.02	0.02	0.02	0.02
Other Long-Term Liabilities	1.61	1.17	1.12	1.12	0.59
Total Liabilities	29.83	15.7	12.79	11.43	8.76
Common Stock	33.67	33.67	33.28	33.28	33.28
Retained Earnings	-18.85	-19.86	-21.78	-23.96	-24.68
Treasury Stock	-0	-0	-0	-0	-0
Comprehensive Income & Other	-0.53	-0.55	-0.56	-0.56	-0.56
Total Common Equity	14.29	13.26	10.94	8.76	8.04
Minority Interest	2.64	-	-	-	-
Shareholders' Equity	16.92	13.26	10.94	8.76	8.04
Total Liabilities & Equity	46.75	28.95	23.73	20.19	16.8
Total Debt	21.15	9.42	7.32	6.05	4.03
Net Cash (Debt)	-9.67	0.15	1.31	3.43	4.1
Net Cash Growth	-	-88.32%	-61.90%	-16.55%	-
Net Cash Per Share	-0.01	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	1,155	1,155	1,120	1,120	1,120
Total Common Shares Outstanding	1,155	1,155	1,120	1,120	1,120
Working Capital	8.3	7.36	8.27	8.01	6.46
Book Value Per Share	0.01	0.01	0.01	0.01	0.01
Tangible Book Value	14.29	13.21	10.94	8.23	7.52
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.01
Machinery	-	14.81	16.42	16.1	15.8
Leasehold Improvements	-	3.24	3.86	3.32	3.32

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.